The treatment of rheumatoid arthritis (RA) has undergone dramatic changes over the past 20 years, which may be subsumed under developing medications, especially methotrexate and biologics. The goals of treating to RA have been formalized by an international task force.
RA is a chronic inflammatory disease which is characterized by pain and swelling of synovial joints. Pain is the most important determinant of the patient’s perception of RA disease activity, while it is mostly the joint swelling for the physician. An international task force emphasizes the importance of shared decision-making with the patients. It is important for medical staffs to identify the discrepancy between the patient’s and the physician’s assessment.
History of changing LLLT in the era of developing medication to RA is showed. Pain relieving effects of LLLT is increasing by using unti-TNF treatments.
The combination treatments of LLLT and medication may be better than the single treatment to aged RA patients.
View full abstract